| BFT | B. fragilis toxin |
| Cag | cytotoxin-associated gene |
| CDDL | cytidine deaminase |
| CDT | cytolethal distending toxin |
| CRC | colorectal cancer |
| CPT-11 | tissue carboxylesterase transforms Irinotecan |
| CTLA4 | anti–cytotoxic T-lymphocyte-associated protein 4 |
| CTX | cyclophosphamide |
| DII® | epidermal growth factor receptor |
| EFAs | essential fatty acids |
| HAAs | heterocyclic aromatic amines |
| HB-EGF | heparin-binding EGF-like growth factor |
| HBV | Hepatitis B |
| HCC | hepatocellular carcinoma |
| HCV | Hepatitis C |
| IBD | inflammatory bowel diseases |
| IL | interleukin |
| MALT | mucosa-associated lymphoid tissue |
| MAPK | mitogen-activated protein kinase |
| NF-κB | nuclear factor-κB |
| NK | natural killer |
| NOCs | N-nitroso compounds |
| NOX2 | NADPH oxidase 2 |
| PAHs | polycyclic aromatic hydrocarbons |
| PD-1 | programmed cell death protein 1 |
| PSA | polysaccharide A |
| ROS | reactive oxygen species |
| RNS | reactive nitrogen species |
| SCFAs | short chain fatty acids |
| STAT3 | signal transducer and activator of transcription 3 |
| TGFβ | Transforming growth factor beta |
| Th | T helper |
| TAMs | tumor-associated macrophages |
| TNF | tumor necrosis factor |